Dermatology Clinical Trials
Explore current trials
Dermatology Clinical Trials in Barrie
Clinical trials are one of the most important tools in medical research. They help determine whether new treatments are safe and effective before reaching the public. These treatments are needed — millions of people still live with conditions that cant be treated.
It takes 10–15 years on average to fully develop a new therapy.
Each trial must meet the highest standards of ethics, medicine, and science. Thanks to decades of progress and commitment from volunteers, today’s trials are leading to treatments that are safer, more targeted, and more effective than ever before.
What's involved?
Participating in a trial means trying the study intervention and providing information to researchers about your experience.
A trial lasts for a set period of weeks or months, and at each stage volunteers attend appointments at the clinic.
Once recruitment completes each trial goes through three phases or periods.
Dermatology Clinical Trials in Barrie
Clinical trials are one of the most important tools in medical research. They help determine whether new treatments are safe and effective before reaching the public. These treatments are needed — millions of people still live with conditions that cant be treated.
It takes 10–15 years on average to fully develop a new therapy.
Each trial must meet the highest standards of ethics, medicine, and science. Thanks to decades of progress and commitment from volunteers, today’s trials are leading to treatments that are safer, more targeted, and more effective than ever before.
What's involved?
Participating in a trial means trying the study intervention and providing information to researchers about your experience.
A trial lasts for a set period of weeks or months, and at each stage volunteers attend appointments at the clinic.
Once recruitment completes each trial goes through three phases or periods.
Screening
Screening is one appointment before the trial begins.
You are encouraged to ask questions and we discuss potential risks and benefits of the trial.
Once you fully understand the details of the trial, we ask for your signed consent to proceed in the trial.
Participation is entirely voluntary, and you can leave at any time for any reason without consequence.
Average appointment time: 2-3 Hours
- Eligibility Review
- Informed Consent
- Medical Assessments
- Trial Specific Procedures
- Q&A & Next Steps
Treatment
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Duration varies by trial from 2 months to over a year.
Est. appointment time: 45-90 minutes
- Administration of investigational treatment
- Medical Assessments & Trial Procedures
Follow-up
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Duration: Varies by trial from 2 weeks to 4 months.
Est. appointment time: 45-90 minutes
- Medical Assessments
Screening
Average appointment time: 2-3 Hours
- Eligibility Review
- Informed Consent
- Medical Assessments
- Trial Specific Procedures
- Q&A & Next Steps
Screening is one appointment before the trial begins.
You are encouraged to ask questions and we discuss potential risks and benefits of the trial.
Once you fully understand the details of the trial, we ask for your signed consent to proceed in the trial.
Participation is entirely voluntary, and you can leave at any time for any reason without consequence.
Treatment
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Duration varies by trial from 2 months to over a year.
- Administration of investigational treatment
- Medical Assessments & Trial Procedures
Treatment
Duration varies by trial from 2 months to over a year.
- Administration of investigational treatment
- Medical Assessments & Trial Procedures
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Follow-Up
Duration varies by trial from 2 weeks to 4 months.
- Medical Assessments
The follow-up stage begins after the treatment period is complete. You’ll stop using the study drug and attend brief check-in appointments over the following weeks or months.
These visits help doctors understand how long the treatment effects last, whether there are any delayed reactions, and how your body continues to respond after stopping the medication.
Screening
Average appointment time: 2-3 Hours
- Eligibility Review
- Informed Consent
- Medical Assessments
- Trial Specific Procedures
- Q&A & Next Steps
Screening is one appointment before the trial begins.
You are encouraged to ask questions and we discuss potential risks and benefits of the trial.
Once you fully understand the details of the trial, we ask for your signed consent to proceed in the trial.
Participation is entirely voluntary, and you can leave at any time for any reason without consequence.
Treatment
Duration: Different for each trial. Two months to over a year.
Est. appointment time: 45-90 minutes
- Administration of investigational treatment
- Medical Assessments & Trial Procedures
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Follow-up
Duration: Varies by trial from 2 weeks to 4 months.
Est. appointment time: 45-90 minutes
- Medical Assessments & Trial Procedures
The follow-up stage begins after the treatment period is complete. You’ll stop using the study drug and attend brief check-in appointments over the following weeks or months.
These visits help doctors understand how long the treatment effects last, whether there are any delayed reactions, and how your body continues to respond after stopping the medication.
Screening
Treatment
Follow-Up
Screening is one appointment before the trial begins.
You are encouraged to ask questions and we discuss potential risks and benefits of the trial.
Once you fully understand the details of the trial, we ask for your signed consent to proceed in the trial.
Participation is entirely voluntary, and you can leave at any time for any reason without consequence.
2-3 Hours
- Eligibility Review
- Informed Consent
- Medical Assessments
- Trial Specific Procedures
- Q&A & Next Steps
The treatment period is the main part of the trial, when you’ll receive either the study drug or a placebo.
Some trials allow participants to switch to the active drug after a set period.
You’ll attend scheduled visits at the clinic for health assessments that help doctors stay on top of your condition and actively research the potential of the study intervention.
Duration varies by trial from 2 months to over a year.
- Administration of investigational treatment
- Medical Assessments & Trial Procedures
The follow-up stage begins after the treatment period is complete. You’ll stop using the study drug and attend brief check-in appointments over the following weeks or months.
These visits help doctors understand how long the treatment effects last, whether there are any delayed reactions, and how your body continues to respond after stopping the medication.
Duration varies by trial from 2 weeks to 4 months.
- Medical Assessments
Meet the doctor
Dr. Maryam Alam
Dr. Maryam Shayesteh Alam is a dermatologist with deep expertise. Particularily in skin cancer. Since 2007, she has been known in the Barrie region for her precision in diagnosing and managing skin cancer and difficult skin conditions.
She leads clinical trials exploring innovative treatments for psoriasis, eczema, vitiligo, alopecia areata, acne, HS, and prurigo nodularis.
With decades of experience, up-to-date clinical knowledge, and a reputation for being both thorough and responsive, Dr. Alam provides exceptional, continuous care to patients referred by family doctors across Simcoe County.
Why Simcoderm
Consistently one of the highest recruiting sites in the world
Trials
Completed
We’re at the forefront of research.
At times the world first to trial new skin therapies.
We’ve earned the trust of sponsors worldwide by getting results they can count on.
Frequently Asked Questions
Call us Mon–Fri.
9:00 a.m. – 4:00 p.m.
#289-763-7666
Or email trialsupportteam@simcoderm.com
Informed consent is a legal and ethical requirement in medical research. It means participants must be fully informed about the study including potential risks, benefits, procedures, and any other important details before deciding to take part.
Consent can only be considered valid when given voluntarily and with a clear understanding of what the trial involves.
Yes. Clinical trials are carefully structured to prioritize participant safety above all else. New treatments are tested in phases, starting with small groups, so doctors can assess safety and effectiveness before moving forward.
At every step of the process, doctors closely monitor participants for symptoms, side effects, and any unexpected changes to ensure the treatment remains safe.
Trial participants often join for two main reasons. First, they may gain access to an investigational treatment that could help improve symptoms of their skin condition.
Second, many people choose to participate because they want to contribute to research and help advance better treatment options for others living with the same condition.
All treatments have potential risks or side effects.
We’ll explain these clearly before you join, and you’ll be supported every step of the way to make sure you feel comfortable and informed.
There is no cost to participate in a clinical trial, and often there is compensation available for time and travel expenses that may occur.
A clinical trial is a planned scientific research experiment that involves volunteers and researchers testing a new medical treatment.
It is a necessary step to better healthcare for diseases that have no cure. By trialling treatments, researchers can learn about their safety and effectiveness.
A placebo is a substance or treatment that looks just like the real study drug but has no active ingredients. It’s used in some clinical trials to help researchers understand whether the investigational treatment works better than no treatment at all.
Participants are always told if there’s a chance they might receive a placebo, and this is explained clearly during the informed consent process.
Yes, research is helping. Over time, the general trend has been toward safer and more effective treatments. Clinical trials make it possible to carefully test new options, refine them, and bring better care to people living with a wide range of conditions.
Progress may happen step by step, but every trial contributes to a bigger picture of improved health outcomes.
Clinical trials are strictly regulated to protect those who participate. In Canada, every trial has to follow strict national laws and international ethical standards. Before the trial starts, an independent ethics board reviews the plan in detail.
Researchers must stick to approved protocols, monitor safety closely, and report results honestly. These checks exist to make sure participants are respected and looked after every step of the way — and to avoid wasting time and resources on treatments that don’t work.
No. You do not need insurance to participate in the trial.
In Canada clinical trials offer compensation only for time and travel expenses. For ethical reasons it is illegal to pay someone to participate in medical research in Canada.
Clinical Trials Department:
Tel #(289)-763-8666
Every clinical trial has specific inclusion and exclusion criteria to ensure the data collected is scientifically valid. Because of this, we encourage anyone who’s interested to apply and we will contact you to determine potential eligibility.
Clinical trials are typically designed and funded by a sponsor, like a pharmaceutical or biotech company. That sponsor is responsible for the overall study.
At SimcoDerm, we act as a clinical trial site, which means our dermatologists and research staff screen participants, administer the treatment, collect data, and monitor safety.
Finally, Health Canada oversees the regulatory side. They don’t run trials directly, but they approve the study before it begins and ensure it follows strict safety and ethical standards.
Call us Mon–Fri.
9:00 a.m. – 4:00 p.m.
#289-763-7666
Or email trialsupportteam@simcoderm.com
Informed consent is a legal and ethical requirement in medical research. It means participants must be fully informed about the study including potential risks, benefits, procedures, and any other important details before deciding to take part.
Consent can only be considered valid when given voluntarily and with a clear understanding of what the trial involves.
Yes. Clinical trials are carefully structured to prioritize participant safety above all else. New treatments are tested in phases, starting with small groups, so doctors can assess safety and effectiveness before moving forward.
At every step of the process, doctors closely monitor participants for symptoms, side effects, and any unexpected changes to ensure the treatment remains safe.
Trial participants often join for two main reasons. First, they may gain access to an investigational treatment that could help improve symptoms of their skin condition.
Second, many people choose to participate because they want to contribute to research and help advance better treatment options for others living with the same condition.
All treatments have potential risks or side effects.
We’ll explain these clearly before you join, and you’ll be supported every step of the way to make sure you feel comfortable and informed.
There is no cost to participate in a clinical trial, and often there is compensation available for time and travel expenses that may occur.
A clinical trial is a planned scientific research experiment that involves volunteers and researchers testing a new medical treatment.
It is a necessary step to better healthcare for diseases that have no cure. By trialling treatments, researchers can learn about their safety and effectiveness.
A placebo is a substance or treatment that looks just like the real study drug but has no active ingredients. It’s used in some clinical trials to help researchers understand whether the investigational treatment works better than no treatment at all.
Participants are always told if there’s a chance they might receive a placebo, and this is explained clearly during the informed consent process.
Yes, research is helping. Over time, the general trend has been toward safer and more effective treatments. Clinical trials make it possible to carefully test new options, refine them, and bring better care to people living with a wide range of conditions.
Progress may happen step by step, but every trial contributes to a bigger picture of improved health outcomes.
In Canada clinical trials offer compensation only for time and travel expenses. For ethical reasons it is illegal to pay someone to participate in medical research in Canada.
Clinical Trials Department:
Tel #(289)-763-8666
Every clinical trial has specific inclusion and exclusion criteria to ensure the data collected is scientifically valid. Because of this, we encourage anyone who’s interested to apply and we will contact you to determine potential eligibility.
Clinical trials are typically designed and funded by a sponsor, like a pharmaceutical or biotech company. That sponsor is responsible for the overall study.
At SimcoDerm, we act as a clinical trial site, which means our dermatologists and research staff screen participants, administer the treatment, collect data, and monitor safety.
Finally, Health Canada oversees the regulatory side. They don’t run trials directly, but they approve the study before it begins and ensure it follows strict safety and ethical standards.
Clinical trials are strictly regulated to protect those who participate. In Canada, every trial has to follow strict national laws and international ethical standards. Before the trial starts, an independent ethics board reviews the plan in detail.
Researchers must stick to approved protocols, monitor safety closely, and report results honestly. These checks exist to make sure participants are respected and looked after every step of the way — and to avoid wasting time and resources on treatments that don’t work.
No. You do not need insurance to participate in the trial.
- 105-5 Quarry Ridge Rd. Barrie, On, L4M 7G1
© 2025 SimcoDerm